If you experience joint pain when you walk or move, promises for a quick and inexpensive cure can be hard to resist. But don’t believe the hype. And don’t assume the people you see in the ads are real.
Unlike drugs, joint pain supplements are not evaluated or reviewed by FDA for safety and effectiveness, and supplements claiming to reduce pain and rebuild cartilage might not be proven to work.
Today the FTC announced a settlement against the makers of Synovia, a purported joint pain relief product, for false advertising claims.
The company claims Synovia is “clinically proven” to rebuild damaged cartilage, reduce arthritis pain by 95%, and provide the same joint pain relief as an injected medication. But the FTC says the company doesn’t have scientific support for these claims.
Don’t let false claims cheat you out of your money or your health. Check out this video about questions you can ask when considering any supplement.
The purpose of this blog and its comments section is to inform readers about Federal Trade Commission activity, and share information to help them avoid, report, and recover from fraud, scams, and bad business practices. Your thoughts, ideas, and concerns are welcome, and we encourage comments. But keep in mind, this is a moderated blog. We review all comments before they are posted, and we won’t post comments that don’t comply with our commenting policy. We expect commenters to treat each other and the blog writers with respect.
- We won’t post off-topic comments, repeated identical comments, or comments that include sales pitches or promotions.
- We won’t post comments that include vulgar messages, personal attacks by name, or offensive terms that target specific people or groups.
- We won’t post threats, defamatory statements, or suggestions or encouragement of illegal activity.
- We won’t post comments that include personal information, like Social Security numbers, account numbers, home addresses, and email addresses. To file a detailed report about a scam, go to ReportFraud.ftc.gov.
We don't edit comments to remove objectionable content, so please ensure that your comment contains none of the above. The comments posted on this blog become part of the public domain. To protect your privacy and the privacy of other people, please do not include personal information. Opinions in comments that appear in this blog belong to the individuals who expressed them. They do not belong to or represent views of the Federal Trade Commission.